CIAM
TMCI icon

Caitong International Asset Management’s Treace Medical Concepts TMCI Stock Holding History

Caitong International Asset Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Sell
3
-57,182
-100% -$114K ﹤0.01% 2350
2025
Q4 		$140K Buy
+57,185
New +$248K 0.03% 305
2025
Q3 		– Sell
-410
Closed -$2.41K – 2516
2025
Q2 		$2.41K Buy
410
+6
+1% +$39 ﹤0.01% 1324
2025
Q1 		$3.39K Buy
+404
New +$3.63K ﹤0.01% 1139

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caitong International Asset Management's TMCI Position: Q1 2026 in Review

Caitong International Asset Management reduced its Treace Medical Concepts (TMCI) stake by 100% in Q1 2026, selling an estimated $114K and leaving 3 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #2350.

Caitong International Asset Management first reported a position in TMCI in Q1 2025 and has held it in 4 quarters since. The position peaked at $140K in Q4 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Caitong International Asset Management held 3 shares of Treace Medical Concepts worth $4 as of Q1 2026.
  • Caitong International Asset Management sold 57,182 Treace Medical Concepts shares in Q1 2026, an estimated $114K.
  • Treace Medical Concepts made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2350 holding.
  • Caitong International Asset Management first reported a position in Treace Medical Concepts in Q1 2025 and has held it in 4 quarters since.
  • Caitong International Asset Management's Treace Medical Concepts position peaked at $140K in Q4 2025.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.